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We read with great interest a recent article by O’Neill
t al. 1 on the implementation of an accelerated postop- 
rative recovery protocol following DIEP flap breast recon- 
truction. Our department has formally introduced a DIEP 
nhanced Recovery After Surgery (ERAS) Pathway in May 
019. We would also like to share the findings of a closed-
oop audit that we recently completed, which reviewed the 
ffectiveness of this pathway and the surgical outcome of 
ur patients. 
Although in a much smaller sample size, our results were 
imilar to this article and we would agree with the authors’
onclusion that implementation of such protocol could ef- 
ectively reduce the length of inpatient stay (LoS) and cost 
f care, without compromising patient care nor increasing 
omplication rates. Prior to the introduction of ERAS Path- 
ay, 28 of our patients who had DIEP between November
018 and May 2019 had an mean LoS of 7.1 days (median
 days, range 5–21 days); whereas 27 patients who experi-
nced the ERAS Pathway between May and December 2019 
ad an mean LoS of 4.8 days (median 5 days, range 3–7
ays). The cost of inpatient stay in a normal ward at our
ospital is approximately £232 per patient per day. Prior 
o the COVID-19 pandemic, there are an estimated of 60 
IEP performed annually at our department. If we extrap- 
late our result, by reducing an extra 2.3 days of inpatient
tay on these 60 patients, the Trust could save at least an
verage of £32,016 per annum. 
Interestingly, we note that amongst the authors’ patient 
ohort, there were patients with BMI up to 46 and active
moker who received microvascular breast reconstruction in 
oth pre- and post-protocol groups. In our department, only 
atients with BMI less than 32 and who have stopped smok-
ng for three months would be listed for DIEP. This is because
oth of these factors can significantly increase the periop- 
rative risks and surgical complications. 2 , 3 For our patients ownloaded for Philip O'Reilly (philip.oreilly@uhb.nhs.uk) at University Hospitals Birming
For personal use only. No other uses without permission.ho do not meet these criteria, our Breast Reconstruction
linical Nurse Specialists would direct them to the right re-
ource and closely follow them up. Once they reach their
arget range, they would be reviewed at outpatient clinic
nd listed for the surgery. 
We also do not routinely commence Aspirin for our DIEP
atients post-operatively, as the authors did for 6 weeks. 
ur patients would only receive low molecular weight hep-
rin (LMWH) whilst they are inpatient post-operatively as 
 form of venous thromboembolism (VTE) prophylaxis and 
his would be discontinued upon discharge. None of our pa-
ients had pulmonary embolism nor deep venous thrombo- 
is. There was one patient in each pre- and post-ERAS group
ho had haematoma and required evacuation; one patient 
ith bilateral DIEP in pre-ERAS group who unfortunately had
otal flap loss. In a systematic review and meta-analysis,
ee and Mun 4 concluded that the use of antithrombotic had
o significant effects on free flap survival and in fact, they
ould increase the incidence of haematoma. On balance, we
hink that the early mobilisation that ERAS advocates and
he use of prophylactic LMWH are sufficient as VTE prophy-
axis in this group of patients. By adding another antithrom-
otic agent, it might in return increase flap complications. 
We do acknowledge the different healthcare system, 
linical practice and patient cohort between UK and Canada
ight explain some of the difference in the delivery of
atient care. The optiFLAPP study 5 published in 2018 has 
lso demonstrated a marked variation in the perioperative 
are of women undergoing abdominal-based microvascu- 
ar breast reconstruction in the UK itself. However, what
e would like to highlight to our readers are the benefits
nd effectiveness of this multimodal, patient-centre and 
vidence-based ERAS. This, perhaps, should be the standard 
f care for all patients who undergo microvascular breast
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